ISRCTN47862456已完成未知
Randomised trial of ifosfamide, carboplatin and etoposide with mid-cycle vincristine (VICE) versus standard practice chemotherapy in patients with limited small cell lung cancer (SCLC) and good performance status
Medical Research Council (MRC) (UK)0 个研究点目标入组 402 人开始时间: 2000年4月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 402
研究概览
简要总结
2005 Results article in http://www.ncbi.nlm.nih.gov/pubmed/16293867 results
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Previously untreated SCLC
- •2. Limited disease
- •3. WHO 0-2
- •4. Normal blood count
- •5. Glomerular Filtration Rate (GFR) greater than 65 ml/min
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
2 期
Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell LymphomaNon-Hodgkins LymphomaNCT00193505SCRI Development Innovations, LLC40
终止
1 期
Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell LymphomaRecurrent Childhood Anaplastic Large Cell LymphomaAnaplastic Large Cell LymphomaNCT00354107National Cancer Institute (NCI)5
招募中
2 期
Adriamycin and Ifosfamide Combined With SintilimabSoft Tissue SarcomaNCT04589754Sun Yat-sen University176
Enrolling By Invitation
2 期
A Phase II Trial of Ifosfamide, Etoposide, Cytarabine, and Methotrexate (IVAM) Chemotherapy for Refractory or Relapsed Diffuse Large B Cell LymphomaDiffuse Large B Cell LymphomaNCT03383406Asan Medical Center30
已完成
2 期
High-dose ICE With AmifostineBrain and Central Nervous System TumorsCarcinoma of Unknown PrimaryExtragonadal Germ Cell TumorHead and Neck CancerKidney CancerTesticular Germ Cell TumorUnspecified Adult Solid Tumor, Protocol SpecificOvarian CancerBladder CancerSarcomaLung CancerNCT00003657Dana-Farber Cancer Institute24